Pre-order Enquiry
Request Free Sample
Global Recombinant Follicle Stimulating Hormone Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-18672211 | Publishing Date : 01-Jul-2021 | No. of pages : 119
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global Recombinant Follicle Stimulating Hormone Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Recombinant Follicle Stimulating Hormone Market Overview1.1 Recombinant Follicle Stimulating Hormone Product Overview
1.2 Recombinant Follicle Stimulating Hormone Market Segment by Type
1.2.1 75IU
1.2.2 150IU
1.2.3 Others
1.3 Global Recombinant Follicle Stimulating Hormone Market Size by Type
1.3.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Type (2016-2027)
1.3.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
1.4.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Type (2016-2021)
2 Global Recombinant Follicle Stimulating Hormone Market Competition by Company
2.1 Global Top Players by Recombinant Follicle Stimulating Hormone Sales (2016-2021)
2.2 Global Top Players by Recombinant Follicle Stimulating Hormone Revenue (2016-2021)
2.3 Global Top Players Recombinant Follicle Stimulating Hormone Price (2016-2021)
2.4 Global Top Manufacturers Recombinant Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Recombinant Follicle Stimulating Hormone Market Competitive Situation and Trends
2.5.1 Recombinant Follicle Stimulating Hormone Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Recombinant Follicle Stimulating Hormone Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2020)
2.7 Date of Key Manufacturers Enter into Recombinant Follicle Stimulating Hormone Market
2.8 Key Manufacturers Recombinant Follicle Stimulating Hormone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Recombinant Follicle Stimulating Hormone Status and Outlook by Region
3.1 Global Recombinant Follicle Stimulating Hormone Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size by Region
3.2.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2016-2021)
3.2.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2016-2021)
3.2.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Region
3.3.1 Global Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2022-2027)
3.3.2 Global Recombinant Follicle Stimulating Hormone Sales in Value by Region (2022-2027)
3.3.3 Global Recombinant Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Recombinant Follicle Stimulating Hormone by Application
4.1 Recombinant Follicle Stimulating Hormone Market Segment by Application
4.1.1 Infertility Treatment
4.1.2 Assisted Reproductive Technology
4.2 Global Recombinant Follicle Stimulating Hormone Market Size by Application
4.2.1 Global Recombinant Follicle Stimulating Hormone Market Size Overview by Application (2016-2027)
4.2.2 Global Recombinant Follicle Stimulating Hormone Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Recombinant Follicle Stimulating Hormone Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Recombinant Follicle Stimulating Hormone Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Recombinant Follicle Stimulating Hormone Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
4.3.2 Europe Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Breakdown by Application (2016-2021)
5 North America Recombinant Follicle Stimulating Hormone by Country
5.1 North America Recombinant Follicle Stimulating Hormone Historic Market Size by Country
5.1.1 North America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021)
5.1.2 North America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021)
5.2 North America Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country
5.2.1 North America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027)
5.2.2 North America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027)
6 Europe Recombinant Follicle Stimulating Hormone by Country
6.1 Europe Recombinant Follicle Stimulating Hormone Historic Market Size by Country
6.1.1 Europe Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021)
6.1.2 Europe Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021)
6.2 Europe Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country
6.2.1 Europe Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027)
6.2.2 Europe Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027)
7 Asia-Pacific Recombinant Follicle Stimulating Hormone by Region
7.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Historic Market Size by Region
7.1.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Forecasted Market Size by Region
7.2.1 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Recombinant Follicle Stimulating Hormone Sales in Value by Region (2022-2027)
8 Latin America Recombinant Follicle Stimulating Hormone by Country
8.1 Latin America Recombinant Follicle Stimulating Hormone Historic Market Size by Country
8.1.1 Latin America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021)
8.1.2 Latin America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021)
8.2 Latin America Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country
8.2.1 Latin America Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027)
8.2.2 Latin America Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027)
9 Middle East and Africa Recombinant Follicle Stimulating Hormone by Country
9.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Historic Market Size by Country
9.1.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Forecasted Market Size by Country
9.2.1 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Recombinant Follicle Stimulating Hormone Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Recombinant Follicle Stimulating Hormone Business
10.1 Merck Serono
10.1.1 Merck Serono Corporation Information
10.1.2 Merck Serono Introduction and Business Overview
10.1.3 Merck Serono Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Merck Serono Recombinant Follicle Stimulating Hormone Products Offered
10.1.5 Merck Serono Recent Development
10.2 MSD
10.2.1 MSD Corporation Information
10.2.2 MSD Introduction and Business Overview
10.2.3 MSD Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Merck Serono Recombinant Follicle Stimulating Hormone Products Offered
10.2.5 MSD Recent Development
10.3 Techwell
10.3.1 Techwell Corporation Information
10.3.2 Techwell Introduction and Business Overview
10.3.3 Techwell Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Techwell Recombinant Follicle Stimulating Hormone Products Offered
10.3.5 Techwell Recent Development
10.4 GenSci
10.4.1 GenSci Corporation Information
10.4.2 GenSci Introduction and Business Overview
10.4.3 GenSci Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.4.4 GenSci Recombinant Follicle Stimulating Hormone Products Offered
10.4.5 GenSci Recent Development
10.5 Gedeon Richter
10.5.1 Gedeon Richter Corporation Information
10.5.2 Gedeon Richter Introduction and Business Overview
10.5.3 Gedeon Richter Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Gedeon Richter Recombinant Follicle Stimulating Hormone Products Offered
10.5.5 Gedeon Richter Recent Development
10.6 Teva
10.6.1 Teva Corporation Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Recombinant Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Teva Recombinant Follicle Stimulating Hormone Products Offered
10.6.5 Teva Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Recombinant Follicle Stimulating Hormone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Recombinant Follicle Stimulating Hormone Industrial Chain Analysis
11.4 Recombinant Follicle Stimulating Hormone Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Recombinant Follicle Stimulating Hormone Distributors
12.3 Recombinant Follicle Stimulating Hormone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Figures, Tables and Charts Available in Global Recombinant Follicle Stimulating Hormone Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Company of 75IU
Table 2. Major Company of 150IU
Table 3. Major Company of Others
Table 4. Global Recombinant Follicle Stimulating Hormone Sales by Type 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 6. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2016-2021)
Table 7. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US& Million)
Table 8. Global Recombinant Follicle Stimulating Hormone Market Share in Value by Type (2016-2021)
Table 9. Global Recombinant Follicle Stimulating Hormone Price by Type (2016-2021) & (USD/Dose)
Table 10. Global Recombinant Follicle Stimulating Hormone Sales by Type (2022-2027) & (K Doses)
Table 11. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2022-2027)
Table 12. Global Recombinant Follicle Stimulating Hormone Sales by Type (2022-2027) & (US$ Million)
Table 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2022-2027)
Table 14. Global Recombinant Follicle Stimulating Hormone Price by Type (2022-2027) & (USD/Dose)
Table 15. North America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (K Doses)
Table 16. North America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million)
Table 17. Europe Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 18. Europe Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million)
Table 19. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 20. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million)
Table 21. Latin America Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 22. Latin America Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million)
Table 23. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021)
Table 24. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Type (2016-2021) & (US$ Million)
Table 25. Global Recombinant Follicle Stimulating Hormone Sales by Company (2016-2021) & (K Doses)
Table 26. Global Recombinant Follicle Stimulating Hormone Sales Share by Company (2016-2021)
Table 27. Global Recombinant Follicle Stimulating Hormone Revenue by Company (2016-2021) & (US$ Million)
Table 28. Global Recombinant Follicle Stimulating Hormone Revenue Share by Company (2016-2021)
Table 29. Global Market Recombinant Follicle Stimulating Hormone Price by Company (2016-2021) & (USD/Dose)
Table 30. Global Recombinant Follicle Stimulating Hormone Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Recombinant Follicle Stimulating Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Recombinant Follicle Stimulating Hormone as of 2020
Table 33. Date of Key Manufacturers Enter into Recombinant Follicle Stimulating Hormone Market
Table 34. Key Manufacturers Recombinant Follicle Stimulating Hormone Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Recombinant Follicle Stimulating Hormone Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027
Table 37. Global Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 38. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2016-2021)
Table 39. Global Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (US$ Million)
Table 40. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2016-2021)
Table 41. Global Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021)
Table 42. Global Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (K Doses)
Table 43. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2022-2027)
Table 44. Global Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (US$ Million)
Table 45. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2022-2027)
Table 46. Global Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2022-2027)
Table 47. Global Recombinant Follicle Stimulating Hormone Sales by Application: 2016 VS 2021 VS 2027 (US$ Million)
Table 48. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (K Doses)
Table 49. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2016-2021)
Table 50. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 51. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2016-2021)
Table 52. Global Recombinant Follicle Stimulating Hormone Price by Application (2016-2021) & (USD/Dose)
Table 53. Global Recombinant Follicle Stimulating Hormone Sales by Application (2022-2027) & (K Doses)
Table 54. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2022-2027)
Table 55. Global Recombinant Follicle Stimulating Hormone Sales by Application (2022-2027) & (US$ Million)
Table 56. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2022-2027)
Table 57. Global Recombinant Follicle Stimulating Hormone Price by Application (2022-2027) & (USD/Dose)
Table 58. North America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses)
Table 59. North America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 60. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Table 61. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses)
Table 62. Europe Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 63. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Table 64. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses)
Table 65. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 66. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Table 67. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses)
Table 68. Latin America Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 69. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Table 70. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) (K Doses)
Table 71. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Application (2016-2021) & (US$ Million)
Table 72. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Table 73. North America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 74. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021)
Table 75. North America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million)
Table 76. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021)
Table 77. North America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 78. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027)
Table 79. North America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million)
Table 80. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027)
Table 81. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 82. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021)
Table 83. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million)
Table 84. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021)
Table 85. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 86. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027)
Table 87. Europe Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million)
Table 88. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027)
Table 89. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses)
Table 90. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2016-2021)
Table 91. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2016-2021) & (US$ Million)
Table 92. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2016-2021)
Table 93. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (K Doses)
Table 94. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Region (2022-2027)
Table 95. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales by Region (2022-2027) & (US$ Million)
Table 96. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Region (2022-2027)
Table 97. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 98. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021)
Table 99. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million)
Table 100. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021)
Table 101. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 102. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027)
Table 103. Latin America Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million)
Table 104. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027)
Table 105. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses)
Table 106. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2016-2021)
Table 107. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2016-2021) & (US$ Million)
Table 108. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2016-2021)
Table 109. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (K Doses)
Table 110. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Country (2022-2027)
Table 111. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales by Country (2022-2027) & (US$ Million)
Table 112. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Country (2022-2027)
Table 113. Merck Serono Corporation Information
Table 114. Merck Serono Introduction and Business Overview
Table 115. Merck Serono Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Merck Serono Recombinant Follicle Stimulating Hormone Product
Table 117. Merck Serono Recent Development
Table 118. MSD Corporation Information
Table 119. MSD Introduction and Business Overview
Table 120. MSD Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. MSD Recombinant Follicle Stimulating Hormone Product
Table 122. MSD Recent Development
Table 123. Techwell Corporation Information
Table 124. Techwell Introduction and Business Overview
Table 125. Techwell Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 126. Techwell Recombinant Follicle Stimulating Hormone Product
Table 127. Techwell Recent Development
Table 128. GenSci Corporation Information
Table 129. GenSci Introduction and Business Overview
Table 130. GenSci Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 131. GenSci Recombinant Follicle Stimulating Hormone Product
Table 132. GenSci Recent Development
Table 133. Gedeon Richter Corporation Information
Table 134. Gedeon Richter Introduction and Business Overview
Table 135. Gedeon Richter Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 136. Gedeon Richter Recombinant Follicle Stimulating Hormone Product
Table 137. Gedeon Richter Recent Development
Table 138. Teva Corporation Information
Table 139. Teva Introduction and Business Overview
Table 140. Teva Recombinant Follicle Stimulating Hormone Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 141. Teva Recombinant Follicle Stimulating Hormone Product
Table 142. Teva Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Recombinant Follicle Stimulating Hormone Market Trends
Table 146. Recombinant Follicle Stimulating Hormone Market Drivers
Table 147. Recombinant Follicle Stimulating Hormone Market Challenges
Table 148. Recombinant Follicle Stimulating Hormone Market Restraints
Table 149. Recombinant Follicle Stimulating Hormone Distributors List
Table 150. Recombinant Follicle Stimulating Hormone Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Follicle Stimulating Hormone Product Picture
Figure 2. Global Recombinant Follicle Stimulating Hormone Market Size, 2016 VS 2021 VS 2027 (US$ Million)
Figure 3. Global Recombinant Follicle Stimulating Hormone Market Size Status and Outlook (2016-2027) & (US$ Million)
Figure 4. Global Recombinant Follicle Stimulating Hormone Sales Status and Outlook (2016-2027) & (K Doses)
Figure 5. Product Picture of 75IU
Figure 6. Global 75IU Sales YoY Growth (2016-2021) & (K Doses)
Figure 7. Product Picture of 150IU
Figure 8. Global 150IU Sales YoY Growth (2016-2021) & (K Doses)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2016-2021) & (K Doses)
Figure 11. Global Recombinant Follicle Stimulating Hormone Sales by Type (2016-2027) & (US$ Million)
Figure 12. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2016-2021)
Figure 13. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2016-2021)
Figure 14. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type (2022-2027)
Figure 15. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type (2022-2027)
Figure 16. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020
Figure 17. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020
Figure 18. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020
Figure 19. Europe Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020
Figure 20. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020
Figure 21. Asia-Pacific Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020
Figure 22. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020
Figure 23. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020
Figure 24. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Type in 2020
Figure 25. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Type in 2020
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Follicle Stimulating Hormone Sales in 2020
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Follicle Stimulating Hormone Revenue in 2020
Figure 28. Recombinant Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Product Picture of Infertility Treatment
Figure 30. Global Infertility Treatment Sales YoY Growth (2016-2027) & (K Doses)
Figure 31. Product Picture of Assisted Reproductive Technology
Figure 32. Global Assisted Reproductive Technology Sales YoY Growth (2016-2027) & (K Doses)
Figure 33. Global Recombinant Follicle Stimulating Hormone Sales by Application (2016-2027) & (US$ Million)
Figure 34. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2016-2021)
Figure 35. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application (2016-2021)
Figure 36. Global Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application (2022-2027)
Figure 37. North America Recombinant Follicle Stimulating Hormone Sales Market Share in Volume by Application in 2020
Figure 38. Latin America Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Figure 39. Middle East and Africa Recombinant Follicle Stimulating Hormone Sales Market Share in Value by Application in 2020
Figure 40. Key Raw Materials Price
Figure 41. Recombinant Follicle Stimulating Hormone Manufacturing Cost Structure
Figure 42. Recombinant Follicle Stimulating Hormone Industrial Chain Analysis
Figure 43. Channels of Distribution
Figure 44. Distributors Profiles
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed
Keyplayers in Global Recombinant Follicle Stimulating Hormone Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturers, Key Regions, Types and Application
Merck SeronoMSD
Techwell
GenSci
Gedeon Richter
Teva
